GlassScriptPhysician profile
Matthew N Rosner
NPI 1497118996
$801.28
in general payments reported to CMS, 2019-2025
13 companies · $15.37 in 2025
The $15.37 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.82 · 2022: $377 · 2023: $233 · 2024: $123 · 2025: $15.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342 · Education: $29.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.86 |
| Education | $29.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $155.14 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $148.22 | 2022-2023 | Dexcom G6 Transmitter |
| Insulet Corporation | $142.68 | 2022 | |
| Radius Health, INC. | $78.58 | 2024 | Tymlos |
| Medtronic, INC. | $71.66 | 2022-2025 | Minimed 780g |
| Lilly USA, LLC | $40.26 | 2021 | |
| Novo Nordisk INC | $39.20 | 2023 | Sogroya |
| Beta Bionics, INC. | $29.43 | 2023-2024 | Ilet Bionic Pancreas |
| Pfizer INC. | $27.89 | 2023 | |
| Alexion Pharmaceuticals, INC. | $26.19 | 2022 | |
| Cequr Corporation | $15.71 | 2022 | |
| Amneal Pharmaceuticals LLC | $13.56 | 2021 | |
| Abbott Laboratories | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Rosner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.